Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Inhibikase Therapeutics Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a 858.33% increase from the last price of 1.20.
High | 1,150.0% | 15.00 |
Med | 858.3% | 11.50 |
Low | 566.7% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +10.91% |
Average growth rate | +14.24% |
More ▼
Revenue history & estimates in USD
Average growth rate | -33.33% |
Average growth rate | +7.67% |
More ▼